Medicine and Dentistry
Anaplastic Large Cell Lymphoma
50%
Bone
50%
Sclerostin
50%
Liver Cirrhosis
50%
Serum
50%
Acute Myeloid Leukemia
50%
Inpatient
50%
Enhancer Region
50%
Patient
37%
Therapeutic Procedure
25%
Prognosis
20%
Bone Density
16%
Neoplasm
16%
Nosology
16%
Epigenomics
16%
microRNA
16%
Carcinogenesis
16%
Diseases
16%
Elderly Patient
16%
Transcription Factor
16%
Diagnosis
16%
Combination Therapy
16%
Hematological Cancer
16%
Comprehension
16%
Mortality
16%
Receptor
13%
Lymphoma Cell
8%
Interleukin 15
8%
Anaplastic Lymphoma Kinase
8%
Enzyme Linked Immunosorbent Assay
5%
Assessment
5%
Alcohol Liver Cirrhosis
5%
Quantitative Computed Tomography
5%
Osteolysis
5%
Bone Turnover
5%
Alcohol Liver Disease
5%
Fracture
5%
Pharmacology, Toxicology and Pharmaceutical Science
Enzyme-Linked Immunosorbent Assay
68%
Sclerostin
50%
Endostatin
50%
Mouse
50%
Acute Myeloid Leukemia
50%
Glomerulonephritis
50%
Biological Marker
50%
Diseases
16%
Neoplasm
16%
Disease Classification
16%
microRNA
16%
Transcription Factor
16%
Carcinogenesis
16%
Mortality
16%
Prognosis
16%
Malignant Neoplasm
16%
Nitrogen
13%
Urea
13%
Rat
9%
Biochemistry, Genetics and Molecular Biology
Sclerostin
100%
Blood Level
59%
Myeloid
50%
Tumor Suppressor Protein
50%
Bone Density
21%
Disease Classification
16%
Comprehension
16%
Molecule
16%
Mortality
16%
Transcription Factor
16%
Epigenetics
16%
Bone
9%
Contrast
5%
Computer Assisted Tomography
5%
Osteolysis
5%
Bone Turnover
5%
